Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of reconciliation of cash and cash equivalents and restricted cash

	March 31, 2023		December 31, 2022		March 31, 2022		December 31, 2021
Cash and cash equivalents	$	7,039,375	$	7,440,030	$	30,653,410	$	36,080,392
Restricted cash		497,055		495,629		468,041		551,794
Total cash and cash equivalents and restricted cash in the condensed consolidated statements of cash flows	$	7,536,430	$	7,935,659	$	31,121,451	$	36,632,186

Schedule of inventories

	March 31, 2023		December 31, 2022
Raw materials and supplies	$	1,259,859	$	1,011,476
Work-in-process		33,245		37,445
Finished goods		2,351,453		2,596,830
Total	$	3,644,557	$	3,645,751

Schedule of finite-lived and indefinite-lived intangible assets

				March 31, 2023								December 31, 2022
	Subsidiary	Cost		Accumulated Amortization and Impairment			Effect of Foreign Exchange Rates			Net Balance		Accumulated Amortization and Impairment			Effect of Foreign Exchange Rates			Net Balance
Trademarks and tradenames	Curetis	$	1,768,000	$	(521,674	)	$	(29,101	)	$	1,217,225	$	(469,011	)	$	(62,520	)	$	1,236,469
Distributor relationships	Curetis		2,362,000		(464,633	)		(38,879	)		1,858,488		(417,728	)		(83,525	)		1,860,747
A50 – Developed technology	Curetis		349,000		(147,126	)		(5,744	)		196,130		(132,273	)		(12,342	)		204,385
Ares – Developed technology	Ares Genetics		5,333,000		(1,123,957	)		(82,553	)		4,126,490		(1,010,495	)		(183,132	)		4,139,373
A30 – In-Process Research & Development	Curetis		5,706,000		(5,612,078	)		(93,922	)		—		(5,407,699	)		(298,301	)		—
		$	15,518,000	$	(7,869,468	)	$	(250,199	)	$	7,398,333	$	(7,437,206	)	$	(639,820	)	$	7,440,974

Schedule of estimated useful lives of identifiable intangible assets

	Estimated Useful Life
Trademarks and tradenames	10 years
Customer/distributor relationships	15 years
A50 – Developed technology	7 years
Ares – Developed technology	14 years
A30 – Acquired in-process research & development	Indefinite

Schedule of expected amortization of intangible assets

Year Ending December 31,
2023 (April to December)	$	564,347
2024		752,463
2025		752,463
2026		752,463
2027		715,644
Thereafter		3,860,953
Total	$	7,398,333